Non-mRNA COVID-19 Vaccine Booster Available at Pharmacy

The U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend that individuals aged 65 and older receive an additional dose of 2023-2024 Formula COVID-19 vaccine four months after receiving the last dose.

According to a Novavax Inc. press release on February 28, 2024, while today's recommendation focuses on protection for older adults at increased risk of COVID-19, information shared at this ACIP meeting also reinforces the ongoing benefit of vaccination for all eligible.

Data from clinical trials continue to show broad long-lived neutralization responses to currently circulating forward-drift variants, including JN.1 and JN.4, for Novavax's protein-based non-mRNA COVID-19 vaccine while maintaining a favorable side effect profile.

Peer-reviewed real-world effectiveness data that shows the immune responses seen in our trials translate into COVID-19 prevention in the real world is being published.

Those interested in a non-mRNA protein-based vaccine should ask their pharmacists about the Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) at major retail pharmacies nationwide, including, but not limited to, Albertsons, CVS Pharmacy and Rite Aid.

Vaccine doses can also be located at us.novavaxcovidvaccine.com or vaccines.gov.

Novavax's Nuvaxovid™ XBB.1.5 is one of 13 COVID-19 vaccines the World Health Organization listed as of early 2024.